Advertisement

The Latest

CMS is raising the bar on provider directory accuracy. For payers, that means more than quarterly updates — it means demonstrating that your network is real, accessible and audit-ready. Ghost networks remain one of the biggest threats to both member…

Oct 16, 2025 11:00 AM - 12:00 PM America/Chicago

Presented by:

Presented by

Presenters

Chris Nolan

Director, Payer Solutions, HealthLink Dimensions

Kimberly Rogers, MBA, RN

Vice President Provider Network and Relations, Peak Health

William Britton

Vice President of Technology, NCD

Michael Kane

Senior Vice President, Provider Data Operations, UnitedHealthcare

Children’s Hospital of Philadelphia has expanded its pediatric heart care services with a new cardiology clinic in Reading, Pa., according to a July 28 news release by the system.  The clinic will operate monthly and offer cardiology evaluations and noninvasive…

UC San Diego Health has opened the McGrath Outpatient Pavilion in San Diego, a $25 million, 250,000-square-foot facility designed to expand access to outpatient, surgical and cancer care, according to a July 28 press release by the system.  Located on…

With colorectal cancer cases rising among younger adults, physicians are warning the public about screening guidelines, access to care and persistent disparities. Four gastroenterologists recently weighed in on their concerns with Becker’s.  Editor’s note: Responses have been lightly edited for…

Hospitals across the U.S. are ramping up investment in outpatient cardiology investment to meet growing demand, lower costs and expand access to care. Yet, despite this growing investment the speciality, as with healthcare as a whole, is facing an emergent…

Insurers are deploying a growing arsenal of strategies to delay, deny or reduce reimbursements, creating major operational and financial strain for ASCs. Becker’s spoke with two ASC leaders about the most common payer strategies they’re seeing and how the resultant…

Adults who develop heart disease often show a steady drop in physical activity starting about 12 years before diagnosis, with low activity levels continuing thereafter, according to a July 23 study published in JAMA Cardiology. Researchers analyzed 34 years of…

The diabetes drug glipizide was linked to a higher risk of serious heart problems compared to dipeptidyl peptidase-4, or DPP4, inhibitors in patients with Type 2 diabetes, according to a study published July 14 in JAMA Network Open. Researchers analyzed…

Advertisement